Related Experiment Videos
Evaluation and treatment of syncope in infants
1Nemours Cardiac Center, AI duPont Hospital for Children, P.O. Box 269, 19899, Wilmington, DE, USA
Insights
Infant syncope, or fainting, can signal serious risks, including sudden infant death. This review guides clinicians in diagnosing and managing fainting in infants under 18 months, emphasizing early identification of at-risk babies.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Clinical Pediatrics
Background:
- Syncope in infants and newborns presents diagnostic challenges due to diverse etiologies.
- It raises concerns as a potential precursor to sudden infant death, causing clinical anxiety.
- Identifying at-risk populations for life-threatening events remains a critical unmet need.
Purpose of the Study:
- To review the differential diagnosis of syncope in children under 18 months.
- To highlight age-specific diagnostic and treatment considerations for infant syncope.
- To provide recommendations for efficient evaluation and management strategies.
Main Methods:
- Comprehensive review of the differential diagnosis of syncope in infants.
- Emphasis on age-specific evaluations, including detailed history and physical examination.
- Consideration of family history, home environment, and emerging diagnostic technologies.
Main Results:
- Syncope in this age group requires careful evaluation due to potential links to sudden infant death.
- Diagnostic approaches must be tailored to the unique physiology and presentation of infants.
- Controversies exist regarding risk factors, home monitoring, and optimal therapeutic strategies.
Conclusions:
- An efficient evaluation for infant syncope necessitates a thorough history, physical exam, and family/environmental assessment.
- Specific diagnostic tests and a practical treatment approach are crucial for managing this condition.
- Further research is needed to define at-risk populations and refine preventive strategies.
Abstract:
Syncope in the infant and newborn occurs as a loss of consciousness due to a variety of etiologies. Because syncope at this age may be a harbinger of sudden infant death, the symptom provokes anxiety and challenges clinicians to identify those babies with an increased risk for life threatening events. Recently introduced diagnostic tests and advances in molecular biology offer promising potential, but the population at risk remains unknown. Controversy surrounds: many potential risk factors; the value of home monitoring; and appropriate preventive and therapeutic strategies. This article reviews the differential diagnosis of syncope in children less than 18 months of age, with particular attention to those diagnoses and problems specific to the evaluation and treatment in this age group. Recommendations are presented for an efficient evaluation, which must include a careful history, complete physical examination and thorough investigation of the family history and home environment. In addition, specific diagnostic tests and a practical approach to treatment are suggested.